Actively Recruiting

Phase Not Applicable
Age: 40Years +
All Genders
NCT05855603

Cardioinhibitory Reflex Syncope. Permanent Pacemaker Therapy or Cardioneuroablation?

Led by Institut d'Investigació Biomèdica de Bellvitge · Updated on 2024-01-25

90

Participants Needed

10

Research Sites

169 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Reflex syncope is the most common form of syncope. It can lead to injuries and affect quality of life. Nonpharmacological and medical therapies have limited effectiveness. In certain patients, cardiac pacing seem to be beneficial. More recently cardioneuroablation (CNA) has emerged as a novel therapy for reflex syncope. The investigators aim to determine whether CNA is more effective than cardiac pacing at reducing the rate of cardioinhibitory-type reflex syncope.

CONDITIONS

Official Title

Cardioinhibitory Reflex Syncope. Permanent Pacemaker Therapy or Cardioneuroablation?

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged more than 40 years.
  • At least two documented reflex syncope episodes in the past 12 months or one episode causing injury plus two presyncope events, unresponsive to standard treatments.
  • Bradycardia-syncope link confirmed by ECG showing at least 3 seconds of asystole during spontaneous syncope.
  • If ECG evidence is lacking, a positive cardioinhibitory response on tilt test (VASIS type 2A or 2B).
  • Indicators for pacing according to ESC guidelines for reflex syncope.
  • Significantly reduced quality of life due to syncope.
  • Sinus rhythm confirmed on ECG.
  • Provided written informed consent.
Not Eligible

You will not qualify if you...

  • Intrinsic sinus or atrioventricular node disease requiring permanent pacemaker implantation.
  • Structural heart disease present.
  • Contraindications to ablation in the right or left atrium.
  • Life expectancy less than 12 months.
  • Unwillingness to comply with randomization.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 10 locations

1

Hospital Universitario San Juan de Alicante

Sant Joan d'Alacant, Alicante, Spain, 03550

Not Yet Recruiting

2

Hospital Universitari General de Castellón

Castellon, Castellón, Spain, 12004

Not Yet Recruiting

3

Hospital Universitario Álvaro Cunqueiro de Vigo

Vigo, Pontevedra, Spain, 36312

Not Yet Recruiting

4

Hospital del Mar

Barcelona, Spain, 08003

Not Yet Recruiting

5

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain, 08025

Not Yet Recruiting

6

Hospital Universitario de Bellvitge

Barcelona, Spain, 08907

Actively Recruiting

7

Hospital Universitari Dr. Josep Trueta

Girona, Spain, 17007

Not Yet Recruiting

8

Hospital Universitario Nuestra Señora de Candelaria

Santa Cruz de Tenerife, Spain, 38010

Not Yet Recruiting

9

Hospital Universitari i Politècnic La Fe

Valencia, Spain, 46026

Not Yet Recruiting

10

Hospital Clínico Universitario Lozano Blesa

Zaragoza, Spain, 50009

Not Yet Recruiting

Loading map...

Research Team

R

Rodolfo San Antonio, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here